APA (7th ed.) Citation

DH, R., A, F., RF, K., JS, T., CD, S., & CM, A. (2026). Identifying Predictors of Weight-Related Outcomes With Fixed-Dose, Extended-Release Naltrexone and Bupropion Among Treatment-Adherent Patients in Phase 3 COR Trials: A Treatment Target Analysis. Obesity science & practice, 12(3), e70159. https://doi.org/10.1002/osp4.70159

Chicago Style (17th ed.) Citation

DH, Ryan, Fitch A, Kushner RF, Tronieri JS, Still CD, and Apovian CM. "Identifying Predictors of Weight-Related Outcomes With Fixed-Dose, Extended-Release Naltrexone and Bupropion Among Treatment-Adherent Patients in Phase 3 COR Trials: A Treatment Target Analysis." Obesity Science & Practice 12, no. 3 (2026): e70159. https://doi.org/10.1002/osp4.70159.

MLA (9th ed.) Citation

DH, Ryan, et al. "Identifying Predictors of Weight-Related Outcomes With Fixed-Dose, Extended-Release Naltrexone and Bupropion Among Treatment-Adherent Patients in Phase 3 COR Trials: A Treatment Target Analysis." Obesity Science & Practice, vol. 12, no. 3, 2026, p. e70159, https://doi.org/10.1002/osp4.70159.